E
Eyal Epstein
Researcher at Israel Institute for Biological Research
Publications - 40
Citations - 779
Eyal Epstein is an academic researcher from Israel Institute for Biological Research. The author has contributed to research in topics: Monoclonal antibody & Antibody. The author has an hindex of 11, co-authored 34 publications receiving 552 citations.
Papers
More filters
Journal ArticleDOI
Transcriptome and proteome analysis of Chinese hamster ovary cells under low temperature and butyrate treatment.
Anne Kantardjieff,Nitya M. Jacob,Joon Chong Yee,Eyal Epstein,Yee Jiun Kok,Robin Philp,Michael J. Betenbaugh,Wei Shou Hu +7 more
TL;DR: It is suggested that elements of the secretory pathway, including Golgi apparatus, cytoskeleton protein binding and small GTPase-mediated signal transduction are enriched and thus may play a role in the increased recombinant protein production observed under butyrate treatment at 33 degrees C.
Journal ArticleDOI
A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes.
Tal Noy-Porat,Efi Makdasi,Ron Alcalay,Adva Mechaly,Yinon Levy,Adi Bercovich-Kinori,Ayelet Zauberman,Hadas Tamir,Yfat Yahalom-Ronen,Ma'ayan Israeli,Eyal Epstein,Hagit Achdout,Sharon Melamed,Theodor Chitlaru,Shay Weiss,Eldar Peretz,Osnat Rosen,Nir Paran,Shmuel Yitzhaki,Shmuel C. Shapira,Tomer Israely,Ohad Mazor,Ronit Rosenfeld +22 more
TL;DR: The isolation and characterization of a panel of human neutralizing monoclonal antibodies targeting the SARS-CoV-2 receptor binding domain (RBD), selected from a phage display library constructed using peripheral circulatory lymphocytes collected from patients at the acute phase of the disease.
Journal ArticleDOI
Contribution of Immunological Memory to Protective Immunity Conferred by a Bacillus anthracis Protective Antigen-Based Vaccine
TL;DR: The practical implications from the studies reported herein are that the protective capacity of memory depends on the PA dose used for the primary immunization and that the effectiveness of booster immunizations for the postexposure treatment of anthrax may be very limited when no detectable antibodies are present in primed animals prior to Bacillus anthracis spore exposure.
Journal ArticleDOI
Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody.
Ronit Rosenfeld,Tal Noy-Porat,Adva Mechaly,Efi Makdasi,Yinon Levy,Ron Alcalay,Reut Falach,Moshe Aftalion,Eyal Epstein,David Gur,Theodor Chitlaru,Einat B. Vitner,Sharon Melamed,Boaz Politi,Ayelet Zauberman,Shirley Lazar,Adi Beth-Din,Yentl Evgy,Shmuel Yitzhaki,Shmuel C. Shapira,Tomer Israely,Ohad Mazor +21 more
Journal ArticleDOI
Isolation of Anti-Ricin Protective Antibodies Exhibiting High Affinity from Immunized Non-Human Primates.
Tal Noy-Porat,Ronit Rosenfeld,Naomi Ariel,Eyal Epstein,Ron Alcalay,Anat Zvi,Chanoch Kronman,Arie Ordentlich,Ohad Mazor +8 more
TL;DR: Six antibodies were found to possess exceptionally high affinity toward the toxin, with KD values below pM (koff < 1 × 10−7 s−1) that were well correlated with their ability to neutralize ricin.